4
Changes in Ownership
KYNTRA BIO, INC. Filed Acc 0001209191-19-038494
Chief Executive Officer sold 39,636 shares at an average $44.20 ($1,752,006)
- Chief Executive Officer acquired 13,668 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Neff Thomas B · Chief Executive Officer
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-06-19 | Exercise or conversion : show line 1 in the form | +6,834 | $2.90 | $19,819 | 2,449,106 | D |
| 2019-06-19 | Sale : show line 2 in the form | −18,400 | $44.02 | $809,968 | 2,430,706 | D |
| 2019-06-19 | Sale : show line 3 in the form | −1,418 | $43.99 | $62,378 | 57,000 | I |
| 2019-06-20 | Exercise or conversion : show line 4 in the form | +6,834 | $2.90 | $19,819 | 2,437,540 | D |
| 2019-06-20 | Sale : show line 5 in the form | −16,200 | $44.28 | $717,336 | 2,421,340 | D |
| 2019-06-20 | Sale : show line 6 in the form | −2,200 | $45.22 | $99,484 | 2,419,140 | D |
| 2019-06-20 | Sale : show line 7 in the form | −1,318 | $44.23 | $58,295 | 55,682 | I |
| 2019-06-20 | Sale : show line 8 in the form | −100 | $45.45 | $4,545 | 55,582 | I |
| Open-market sales · 39,636 sh · avg $44.20 · $1,752,006 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2019-06-19 | Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) | −6,834 | $2.90 | 2020-06-09 | 6,834 | 239,208 | D |
| 2019-06-20 | Exercise or conversion : show line 10 in the form Stock Option (Right to Buy) | −6,834 | $2.90 | 2020-06-09 | 6,834 | 232,374 | D |
Loading xslF345X03/doc4.xml…